{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:38:41Z","timestamp":1775018321538,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychiatr Q"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11126-020-09830-6","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T09:04:17Z","timestamp":1598519057000},"page":"1147-1192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effectiveness and Safety of Ketamine for Unipolar Depression: a Systematic Review"],"prefix":"10.1007","volume":"91","author":[{"given":"Raheel Imtiaz","family":"Memon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadiq","family":"Naveed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber Ehsan","family":"Faquih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ania","family":"Fida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noureen","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amna Mohyud Din","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheala","family":"Qayyum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"issue":"2","key":"9830_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","volume":"75","author":"EJ Daly","year":"2018","unstructured":"Daly EJ, Singh JB, Fedgchin M, Cooper K, Lim P, Shelton RC, et al. Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial. JAMA Psychiat. 2018;75(2):139\u201348. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.3739.","journal-title":"JAMA Psychiat"},{"key":"9830_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jad.2016.05.011","volume":"201","author":"X Zhong","year":"2016","unstructured":"Zhong X, He H, Zhang C, Wang Z, Jiang M, Li Q, et al. Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression. J Affect Disord. 2016;201:124\u201330. https:\/\/doi.org\/10.1016\/j.jad.2016.05.011.","journal-title":"J Affect Disord"},{"key":"9830_CR3","doi-asserted-by":"publisher","unstructured":"Liu Q, He H, Yang J, Feng X, Zhao F, Lyu J. Changes in the global burden of depression from 1990 to 2017: Findings from the Global Burden of Disease study. J Psychiatr Res. 2019;(August):1\u20137. https:\/\/doi.org\/10.1016\/j.jpsychires.2019.08.002","DOI":"10.1016\/j.jpsychires.2019.08.002"},{"key":"9830_CR4","doi-asserted-by":"publisher","unstructured":"Faquih AE, Memon RI, Hafeez H, Zeshan M, Naveed S. A review of novel antidepressants: a guide for clinicians. Cureus. 2019;11(3). https:\/\/doi.org\/10.7759\/cureus.4185","DOI":"10.7759\/cureus.4185"},{"issue":"2","key":"9830_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4088\/JCP.14m09298","volume":"76","author":"PE Greenberg","year":"2015","unstructured":"Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 2015;76(2):155\u201362. https:\/\/doi.org\/10.4088\/JCP.14m09298.","journal-title":"J Clin Psychiatry"},{"issue":"16","key":"9830_CR6","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1017\/S0033291715001506","volume":"45","author":"JW Murrough","year":"2015","unstructured":"Murrough JW, Soleimani L, Dewilde KE, et al. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial. Psychol Med. 2015;45(16):3571\u201380. https:\/\/doi.org\/10.1017\/S0033291715001506.","journal-title":"Psychol Med"},{"key":"9830_CR7","unstructured":"Williams RD. Characteristics of completed sucides. Psychiatr Times. 2016."},{"issue":"2","key":"9830_CR8","first-page":"142","volume":"27","author":"M Zeshan","year":"2018","unstructured":"Zeshan M, Waqas A, Naveed S, Ghulam H, Manocha P. Factors predicting length of stay in an adolescent psychiatric unit, south Bronx, NY: a short report. J Can Acad Child Adolesc Psychiatry. 2018;27(2):142\u20137.","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"issue":"1","key":"9830_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/acps.12572","volume":"134","author":"CK Loo","year":"2016","unstructured":"Loo CK, G\u00e1lvez V, O\u2019Keefe E, et al. Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression. Acta Psychiatr Scand. 2016;134(1):48\u201356. https:\/\/doi.org\/10.1111\/acps.12572.","journal-title":"Acta Psychiatr Scand"},{"key":"9830_CR10","doi-asserted-by":"publisher","unstructured":"Grunebaum, M. F., Galfalvy, H. C., Choo, T. H., Keilp, J. G., Moitra, V. K., Parris, M. S., ... & Oquendo MA. Ketamine for rapid reduction of suicidal thoughts in major depression: a midazoam-controlled randomized clinical trial. Am J Psychiatry 2018;175(5):327\u2013335. doi:https:\/\/doi.org\/10.1038\/nm.2451.A.","DOI":"10.1038\/nm.2451.A"},{"issue":"3","key":"9830_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/YCT.0b013e31824f8296","volume":"28","author":"CG Abdallah","year":"2012","unstructured":"Abdallah CG, Fasula M, Kelmendi B, Sanacora G, Ostroff R. Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting. J ECT. 2012;28(3):157\u201361. https:\/\/doi.org\/10.1097\/YCT.0b013e31824f8296.","journal-title":"J ECT"},{"issue":"10","key":"9830_CR12","doi-asserted-by":"publisher","first-page":"S411","DOI":"10.1016\/s0924-977x(13)70651-5","volume":"23","author":"JW Murrough","year":"2013","unstructured":"Murrough JW, Iosifescu DV, Chang L, al Jurdi RK, Green C, Perez A, et al. P.2.F.028 antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site, randomised controlled trial. Eur Neuropsychopharmacol. 2013;23(10):S411\u20132. https:\/\/doi.org\/10.1016\/s0924-977x(13)70651-5.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1\u20132","key":"9830_CR13","first-page":"57","volume":"55","author":"P Sos","year":"2013","unstructured":"Sos P, Klirova M, Novak T, Kohutova B, Horacek J, Palenice T. Relationship of ketamine\u2019s antidepressant and psychotomimetic effects in unipolar depression. Act Nerv Super Rediviva. 2013;55(1\u20132):57\u201363.","journal-title":"Act Nerv Super Rediviva"},{"issue":"2","key":"9830_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/eme04020","volume":"4","author":"IM Anderson","year":"2017","unstructured":"Anderson IM, Blamire A, Branton T, Brigadoi S, Clark R, Downey D, et al. Randomised controlled trial of ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (ketamine-ECT study). Effic Mech Eval. 2017;4(2):1\u2013112. https:\/\/doi.org\/10.3310\/eme04020.","journal-title":"Effic Mech Eval"},{"issue":"4","key":"9830_CR15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/ANA.0000000000000511","volume":"30","author":"CW Carspecken","year":"2018","unstructured":"Carspecken CW, Borisovskaya A, Lan ST, Heller K, Buchholz J, Ruskin D, et al. Ketamine anesthesia does not improve depression scores in electroconvulsive therapy: a randomized clinical trial. J Neurosurg Anesthesiol. 2018;30(4):305\u201313. https:\/\/doi.org\/10.1097\/ANA.0000000000000511.","journal-title":"J Neurosurg Anesthesiol"},{"issue":"3","key":"9830_CR16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/YCT.0b013e318283b7e9","volume":"29","author":"K J\u00e4rventausta","year":"2013","unstructured":"J\u00e4rventausta K, Chrapek W, Kampman O, Tuohimaa K, Bj\u00f6rkqvist M, H\u00e4kkinen H, et al. Effects of S-ketamine as an anesthetic adjuvant to propofol on treatment response to electroconvulsive therapy in treatment-resistant depression: a randomized pilot study. J ECT. 2013;29(3):158\u201361. https:\/\/doi.org\/10.1097\/YCT.0b013e318283b7e9.","journal-title":"J ECT"},{"issue":"6","key":"9830_CR17","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.biopsych.2015.10.018","volume":"80","author":"JB Singh","year":"2016","unstructured":"Singh JB, Fedgchin M, Daly E, Xi L, Melman C, de Bruecker G, et al. Intravenous Esketamine in adult treatment-resistant depression: a double-blind, double-randomization, placebo-controlled study. Biol Psychiatry. 2016;80(6):424\u201331. https:\/\/doi.org\/10.1016\/j.biopsych.2015.10.018.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"9830_CR18","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s00404-017-4334-8","volume":"295","author":"Y Xu","year":"2017","unstructured":"Xu Y, Li Y, Huang X, Chen D, She B, Ma D. Single bolus low-dose of ketamine does not prevent postpartum depression: a randomized, double-blind, placebo-controlled, prospective clinical trial. Arch Gynecol Obstet. 2017;295(5):1167\u201374. https:\/\/doi.org\/10.1007\/s00404-017-4334-8.","journal-title":"Arch Gynecol Obstet"},{"issue":"10","key":"9830_CR19","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.7205\/milmed-d-15-00431","volume":"181","author":"J Burger","year":"2016","unstructured":"Burger J, Capobianco M, Lovern R, Boche B, Ross E, Darracq MA, et al. A double-blinded, randomized, placebo-controlled sub-dissociative dose ketamine pilot study in the treatment of acute depression and Suicidality in a military emergency department setting. Mil Med. 2016;181(10):1195\u20139. https:\/\/doi.org\/10.7205\/milmed-d-15-00431.","journal-title":"Mil Med"},{"issue":"6","key":"9830_CR20","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s12630-018-1088-0","volume":"65","author":"JJ Gamble","year":"2018","unstructured":"Gamble JJ, Bi H, Bowen R, Weisgerber G, Sanjanwala R, Prasad R, et al. Ketamine-based anesthesia improves electroconvulsive therapy outcomes: a randomized-controlled studyL\u2019anesth\u00e9sie \u00e0 base de k\u00e9tamine am\u00e9liore les r\u00e9sultats de l\u2019\u00e9lectro-convulsivoth\u00e9rapie : une \u00e9tude randomis\u00e9e contr\u00f4l\u00e9e. Can J Anesth Can d\u2019anesth\u00e9sie. 2018;65(6):636\u201346. https:\/\/doi.org\/10.1007\/s12630-018-1088-0.","journal-title":"Can J Anesth Can d\u2019anesth\u00e9sie"},{"issue":"3","key":"9830_CR21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1017\/S0033291715002159","volume":"46","author":"YD Hu","year":"2016","unstructured":"Hu YD, Xiang YT, Fang JX, Zu S, Sha S, Shi H, et al. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study. Psychol Med. 2016;46(3):623\u201335. https:\/\/doi.org\/10.1017\/S0033291715002159.","journal-title":"Psychol Med"},{"issue":"3","key":"9830_CR22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.22088\/cjim.9.3.220","volume":"9","author":"F Kheirkhah","year":"2018","unstructured":"Kheirkhah F, Tayyebi G, Rabiee SM, Moghadamnia AA, Bijani A. Efficacy of different doses of ketamine as a bolus in major depressive disorder. Casp J Intern Med. 2018;9(3):220\u20137. https:\/\/doi.org\/10.22088\/cjim.9.3.220.","journal-title":"Casp J Intern Med"},{"issue":"8","key":"9830_CR23","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate","year":"2006","unstructured":"Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63(8):856\u201364. https:\/\/doi.org\/10.1001\/archpsyc.63.8.856.","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"9830_CR24","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3109\/15622975.2014.922697","volume":"15","author":"R Lai","year":"2014","unstructured":"Lai R, Katalinic N, Glue P, Somogyi AA, Mitchell PB, Leyden J, et al. Pilot dose-response trial of I.V. ketamine in treatment-resistant depression. World J Biol Psychiatry. 2014;15(7):579\u201384. https:\/\/doi.org\/10.3109\/15622975.2014.922697.","journal-title":"World J Biol Psychiatry"},{"issue":"4","key":"9830_CR25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.4103\/0971-9784.166444","volume":"18","author":"B Salehi","year":"2015","unstructured":"Salehi B, Mohammadbeigi A, Kamali AR, Taheri-Nejad MR, Moshiri I. Impact comparison of ketamine and sodium thiopental on anesthesia during electroconvulsive therapy in major depression patients with drug-resistant; a double-blind randomized clinical trial. Ann Card Anaesth. 2015;18(4):486\u201390. https:\/\/doi.org\/10.4103\/0971-9784.166444.","journal-title":"Ann Card Anaesth"},{"key":"9830_CR26","unstructured":"Xu R, Zhan Y, Chen S. Effect of intraoperative single administration of sub-anesthesia ketamine on breast cancer patients with depression. Biomed Res. 2017;2017(Special Issue HealthScienceandBioConvergenceTechnologyEdition-II):S552-S556."},{"issue":"2","key":"9830_CR27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s00540-015-2096-7","volume":"30","author":"M Jiang","year":"2016","unstructured":"Jiang M, Wang MH, Wang X. Bin, et al. effect of intraoperative application of ketamine on postoperative depressed mood in patients undergoing elective orthopedic surgery. J Anesth. 2016;30(2):232\u20137. https:\/\/doi.org\/10.1007\/s00540-015-2096-7.","journal-title":"J Anesth"},{"issue":"1","key":"9830_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/00000539-200207000-00020","volume":"95","author":"A Kudoh","year":"2002","unstructured":"Kudoh A, Takahira Y, Katagai H, Takazawa T. Small-dose ketamine improves the postoperative state of depressed patients. Anesth Analg. 2002;95(1):114\u20138. https:\/\/doi.org\/10.1097\/00000539-200207000-00020.","journal-title":"Anesth Analg"},{"issue":"2","key":"9830_CR29","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.18632\/oncotarget.13743","volume":"8","author":"W Fan","year":"2017","unstructured":"Fan W, Yang HK, Sun Y, et al. Ketamine rapidly relieves acute suicidal ideation in cancer patients: A randomized controlled clinical trial. Oncotarget. 2017;8(2):2356\u201360. https:\/\/doi.org\/10.18632\/oncotarget.13743.","journal-title":"Oncotarget"},{"key":"9830_CR30","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41380-018-0256-5","volume":"25","author":"M Fava","year":"2018","unstructured":"Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, et al. Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Mol Psychiatry. 2018;25:1592\u2013603. https:\/\/doi.org\/10.1038\/s41380-018-0256-5.","journal-title":"Mol Psychiatry"},{"issue":"13","key":"9830_CR31","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1038\/npp.2017.94","volume":"42","author":"TP Su","year":"2017","unstructured":"Su TP, Chen MH, Li CT, Lin WC, Hong CJ, Gueorguieva R, et al. Dose-related effects of adjunctive ketamine in taiwanese patients with treatment-resistant depression. Neuropsychopharmacology. 2017;42(13):2482\u201392. https:\/\/doi.org\/10.1038\/npp.2017.94.","journal-title":"Neuropsychopharmacology."},{"issue":"2","key":"9830_CR32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.psychres.2013.12.008","volume":"215","author":"M Ghasemi","year":"2014","unstructured":"Ghasemi M, Kazemi MH, Yoosefi A, Ghasemi A, Paragomi P, Amini H, et al. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder. Psychiatry Res. 2014;215(2):355\u201361. https:\/\/doi.org\/10.1016\/j.psychres.2013.12.008.","journal-title":"Psychiatry Res"},{"key":"9830_CR33","doi-asserted-by":"publisher","unstructured":"Alizadeh NS, Maroufi A, Nasseri K, et al. Antidepressant effect of combined ketamine and electroconvulsive therapy on patients with major depressive disorder: A randomized trial. Iran J Psychiatry Behav Sci. 2015;9(3). https:\/\/doi.org\/10.17795\/ijpbs-1578","DOI":"10.17795\/ijpbs-1578"},{"issue":"2","key":"9830_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/YCT.0000000000000365","volume":"33","author":"Q Chen","year":"2017","unstructured":"Chen Q, Min S, Hao X, Peng L, Meng H, Luo Q, et al. Effect of low dose of ketamine on learning memory function in patients undergoing electroconvulsive therapy-a randomized, double-blind, controlled clinical study. J ECT. 2017;33(2):89\u201395. https:\/\/doi.org\/10.1097\/YCT.0000000000000365.","journal-title":"J ECT"},{"issue":"6","key":"9830_CR35","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1192\/bjp.bp.116.189134","volume":"210","author":"G Fernie","year":"2017","unstructured":"Fernie G, Currie J, Perrin JS, Stewart CA, Anderson V, Bennett DM, et al. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial. Br J Psychiatry. 2017;210(6):422\u20138. https:\/\/doi.org\/10.1192\/bjp.bp.116.189134.","journal-title":"Br J Psychiatry"},{"issue":"2","key":"9830_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/YCT.0b013e31824d1d02","volume":"28","author":"X Wang","year":"2012","unstructured":"Wang X, Chen Y, Zhou X, Liu F, Zhang T, Zhang C. Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorder. J ECT. 2012;28(2):128\u201332. https:\/\/doi.org\/10.1097\/YCT.0b013e31824d1d02.","journal-title":"J ECT"},{"issue":"1","key":"9830_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/YCT.0b013e3182a4b4c6","volume":"30","author":"A Yoosefi","year":"2014","unstructured":"Yoosefi A, Sepehri AS, Kargar M, Akhondzadeh S, Sadeghi M, Rafei A, et al. Comparing effects of ketamine and thiopental administration during electroconvulsive therapy in patients with major depressive disorder: a randomized, double-blind study. J ECT. 2014;30(1):15\u201321. https:\/\/doi.org\/10.1097\/YCT.0b013e3182a4b4c6.","journal-title":"J ECT"},{"issue":"3","key":"9830_CR38","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3109\/15622975.2016.1142607","volume":"17","author":"EJ Lenze","year":"2016","unstructured":"Lenze EJ, Farber NB, Kharasch E, Schweiger J, Yingling M, Olney J, et al. Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: a pilot randomised controlled trial. World J Biol Psychiatry. 2016;17(3):230\u20138. https:\/\/doi.org\/10.3109\/15622975.2016.1142607.","journal-title":"World J Biol Psychiatry"},{"issue":"12","key":"9830_CR39","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.biopsych.2014.03.026.A","volume":"76","author":"KAB Lapidus","year":"2015","unstructured":"Lapidus KAB, Levitch CF, Perez AM, et al. NIH Public Access. 2015;76(12):970\u20136. https:\/\/doi.org\/10.1016\/j.biopsych.2014.03.026.A.","journal-title":"NIH Public Access"},{"issue":"7","key":"9830_CR40","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1176\/appi.ajp.2018.17060720","volume":"175","author":"CM Canuso","year":"2018","unstructured":"Canuso CM, Singh JB, Fedgchin M, Alphs L, Lane R, Lim P, et al. Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study. Am J Psychiatry. 2018;175(7):620\u201330. https:\/\/doi.org\/10.1176\/appi.ajp.2018.17060720.","journal-title":"Am J Psychiatry"},{"issue":"February","key":"9830_CR41","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jad.2018.02.056","volume":"235","author":"S Arabzadeh","year":"2018","unstructured":"Arabzadeh S, Hakkikazazi E, Shahmansouri N, Tafakhori A, Ghajar A, Jafarinia M, et al. Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial. J Affect Disord. 2018;235(February):236\u201341. https:\/\/doi.org\/10.1016\/j.jad.2018.02.056.","journal-title":"J Affect Disord"},{"key":"9830_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2016.05.076","volume":"204","author":"M Jafarinia","year":"2016","unstructured":"Jafarinia M, Afarideh M, Tafakhori A, Arbabi M, Ghajar A, Noorbala AA, et al. Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: a double-blind, randomized, controlled trial. J Affect Disord. 2016;204:1\u20138. https:\/\/doi.org\/10.1016\/j.jad.2016.05.076.","journal-title":"J Affect Disord"},{"issue":"2","key":"9830_CR43","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1017\/S1461145713001119","volume":"17","author":"CN Haile","year":"2014","unstructured":"Haile CN, Murrough JW, Iosifescu DV, Chang LC, al Jurdi RK, Foulkes A, et al. Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. Int J Neuropsychopharmacol. 2014;17(2):331\u20136. https:\/\/doi.org\/10.1017\/S1461145713001119.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"9830_CR44","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1017\/S0033291714001603","volume":"45","author":"A McGirr","year":"2015","unstructured":"McGirr A, Berlim MT, Bond DJ, Fleck MP, Yatham LN, Lam RW. A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes. Psychol Med. 2015;45(4):693\u2013704. https:\/\/doi.org\/10.1017\/S0033291714001603.","journal-title":"Psychol Med"},{"issue":"10","key":"9830_CR45","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","volume":"172","author":"DJ Newport","year":"2015","unstructured":"Newport DJ, Carpenter LL, McDonald WM, Potash JB, Tohen M, Nemeroff CB. Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression. Am J Psychiatry. 2015;172(10):950\u201366. https:\/\/doi.org\/10.1176\/appi.ajp.2015.15040465.","journal-title":"Am J Psychiatry"},{"key":"9830_CR46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jpsychires.2015.01.003","volume":"62","author":"A McGirr","year":"2015","unstructured":"McGirr A, Berlim MT, Bond DJ, Neufeld NH, Chan PY, Yatham LN, et al. A systematic review and meta-analysis of randomized controlled trials of adjunctive ketamine in electroconvulsive therapy: efficacy and tolerability. J Psychiatr Res. 2015;62:23\u201330. https:\/\/doi.org\/10.1016\/j.jpsychires.2015.01.003.","journal-title":"J Psychiatr Res"},{"issue":"5","key":"9830_CR47","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S2215-0366(17)30077-9","volume":"4","author":"IM Anderson","year":"2017","unstructured":"Anderson IM, Blamire A, Branton T, Clark R, Downey D, Dunn G, et al. Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial. Lancet Psychiatry. 2017;4(5):365\u201377. https:\/\/doi.org\/10.1016\/S2215-0366(17)30077-9.","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"9830_CR48","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S2215-0366(17)30099-8","volume":"4","author":"CH Kellner","year":"2017","unstructured":"Kellner CH, Iosifescu DV. Ketamine and ECT: better alone than together? Lancet Psychiatry. 2017;4(5):348\u20139. https:\/\/doi.org\/10.1016\/S2215-0366(17)30099-8.","journal-title":"Lancet Psychiatry"},{"key":"9830_CR49","unstructured":"FDA. FDA approves new nasal spray medication for treatment-resistant depression. FDA News Release. 2019."},{"key":"9830_CR50","volume-title":"Spravato: Package Insert","author":"JP Companies","year":"2020","unstructured":"Companies JP. Spravato: Package Insert. 2020."},{"key":"9830_CR51","doi-asserted-by":"crossref","unstructured":"Andrade C. Andrade, C. (2017). Ketamine for depression, 4: in what dose, at what rate, by what route, for how long, and at what frequency?. The Journal of clinical psychiatry, 78(7), e852-e857. 2017;81(April).","DOI":"10.4088\/JCP.17f11738"},{"key":"9830_CR52","unstructured":"Rosenbaum, S.B., Gupta, V,. & Palacios JL. Ketamine. Statpearls Publishing; 2018."}],"container-title":["Psychiatric Quarterly"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-020-09830-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11126-020-09830-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-020-09830-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T23:34:38Z","timestamp":1630020878000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11126-020-09830-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["9830"],"URL":"https:\/\/doi.org\/10.1007\/s11126-020-09830-6","relation":{},"ISSN":["0033-2720","1573-6709"],"issn-type":[{"value":"0033-2720","type":"print"},{"value":"1573-6709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,27]]},"assertion":[{"value":"27 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure of Potential Conflicts of Interest"}},{"value":"Not applicable since it is a review article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human Participants and\/or Animals"}},{"value":"Not applicable since it is a review article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}